1-3 of 3
Syed Muhammad Ali Najafi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world outcomes of epcoritamab in relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) following CAR T-cell therapy: A multicenter retrospective study from the trinetx global network

Free
Syed Naqvi, Ejaz Shah, Firas Jafri, Syed Muhammad Ali Najafi, Manpreet Saini, Syed Abutalib, Maurizio Zangari, Frits van Rhee, Ankur Varma
Journal: Blood
Blood (2025) 146 (Supplement 1): 7247.
https://doi.org/10.1182/blood-2025-7247
Published: 2025
Journal Articles

Outcomes with a fixed duration combination of bruton tyrosine kinase inhibitors and venetoclax in chronic lymphocytic leukemia: A systematic review and meta-analysis

Free
Hafiz Muhammad Hannan Javed, Farooq Ashraf, Fatima Sial, Hafsa Shahid, Syed Muhammad Ali Najafi, Atif Butt, Muhammad Shaheer Mannan, Muhammad Umair Mushtaq, Moazzam Shahzad
Journal: Blood
Blood (2025) 146 (Supplement 1): 7432.
https://doi.org/10.1182/blood-2025-7432
Published: 2025
Journal Articles

Temporal Trends and Demographic Disparities in Mortality from Heart Failure with Co-Existing Iron Deficiency Anemia in the United States, 1999-2020

Free
Fatima Zafar, Syed Muhammad Ali Najafi, Muhammad Imtanan Fazal, Fnu Shubhangi, Vaibhavi P Mukhtiar, Umer Talal, Malik Ahsan Safdar, Muhammad Romail Manan, Iqra Nawaz, Ammad Naeem
Journal: Blood
Blood (2024) 144 (Supplement 1): 2326.
https://doi.org/10.1182/blood-2024-209846
Published: 2024